Jump to a slide with the slide dots.
When bringing cell and gene therapies (CGTs) to market, developers must successfully navigate various obstacles, including the technical aspects of...
Read moreA global narrative was required to tell the scientific story for a client launching a new class of multiple sclerosis monoclonal antibody treatment.
Read more